Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Primary Objective: To define the Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 Dose (RP2D) of CP-751,871 in adolescents (10-18 years). Phase 2 To define the efficacy of CP-751,871, in terms of objective response rate, in patients with relapsed/refractory Ewing’s sarcoma family of tumors.
Inclusion criteria
- Ewing's sarcoma family tumours